Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications E. J. SmoldersC. T. M. M. de KanterD. M. Burger Review Article Open access 17 June 2016 Pages: 1471 - 1494
A Comprehensive Review of Treprostinil Pharmacokinetics via Four Routes of Administration Parag KumarEmily ThudiumAndrew Nelsen Review Article Open access 10 June 2016 Pages: 1495 - 1505
Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient Populations Antonio TorresJohan Willem MoutonFederico Pea Review Article Open access 07 June 2016 Pages: 1507 - 1520
Population Genetic-Based Pharmacokinetic Modeling of Methadone and its Relationship with the QTc Interval in Opioid-Dependent Patients Chantal CsajkaSéverine CrettolChin B. Eap Original Research Article 10 June 2016 Pages: 1521 - 1533
Dose-Dependent Bioavailability and CYP3A Inhibition Contribute to Non-Linear Pharmacokinetics of Voriconazole Nicolas HohmannFranziska KocheiseGerd Mikus Original Research Article 28 May 2016 Pages: 1535 - 1545
Pharmacokinetics, Safety and Tolerability of ABT-494, a Novel Selective JAK 1 Inhibitor, in Healthy Volunteers and Subjects with Rheumatoid Arthritis Mohamed-Eslam F. MohamedHeidi S. CampAhmed A. Othman Original Research Article 06 June 2016 Pages: 1547 - 1558
Using Population Pharmacokinetic and Pharmacodynamic Analyses of Entecavir in Pediatric Subjects to Simplify Dosing Recommendations Phyllis ChanDiane R. MouldMarc Bifano Original Research Article 18 June 2016 Pages: 1559 - 1572
Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals Jan-Frederik SchlenderMichaela MeyerUlrich Jaehde Original Research Article Open access 28 June 2016 Pages: 1573 - 1589
